Results

Total Results: 428 records

Showing results for "grade d cancer".

  1. Slide 1 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
    September 13, 2006 - change consumer behavior, primarily through risk communication Good examples from prostate & breast cancer … information to consumers to counter inaccurate messages or promote informed decisions (e.g., Medicare Part D) … 0.8132422 0.000 pctotfund2 0.973652 0.033 rprice 0.9999468 1.000 _Idma* 10th Grade … change consumer behavior, primarily through risk communication Good examples from prostate & breast cancer … information to consumers to counter inaccurate messages or promote informed Medicare decision making (Part D)
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - D. … Strength of evidence grades and definitions Grade Definition High High confidence that the evidence … Misdrahi D, Llorca PM, Lancon C, et al. … Tanioka D, Iwasaki Y, Araki Y, et al. … The revised criteria table is attached (Appendix D).
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
    February 25, 2014 - We have removed Tables C and D, and replaced them with Figures C, D, E and Table F. … For example, in Table D, Natalizumab vs. … serious adverse event such as mortality, progressive multifocal leukoencephalopathy, lymphoma, or other cancers … Recommendation: Lymphoma or other cancers have been reported in pediatric patients, by stating in this … No deaths, malignancies, demyelinating disorders, optic neuritis, seizures, or new cases of autoimmune
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
    February 01, 2023 - Gungor D, Nadaud P, Dreibelbis C, et al. … Gungor D, Nadaud P, Dreibelbis C, et al. … Gungor D, Nadaud P, LaPergola CC, et al. … Dewey KG, Gungor D, Donovan SM, et al. … Wells GA, Shea B, O'Connell D, et al.
  5. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Guyatt G, Rennie D, Meade M, et al. … Polus S, Pieper D, Burns J, et al. … Mack C, Su Z, Westreich D. … Wells GA, Shea B, O'Connell D, et al. … Clark E, Burkett K, Stanko-Lopp D.
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Guyatt G, Rennie D, Meade M, et al. … Polus S, Pieper D, Burns J, et al. … Mack C, Su Z, Westreich D. … Wells GA, Shea B, O'Connell D, et al. … Clark E, Burkett K, Stanko-Lopp D.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - prevent the long-term health complications associated with HCV infection such as cirrhosis and liver cancer … associated with continued freedom from viremia as well as reductions in mortality, liver failure, and cancerD. … Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C. … Owens DK, Lohr KN, Atkins D et al.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/skin-lesions-evaluation_disposition-comments.pdf
    September 01, 2011 - Noninvasive Diagnostic Techniques for the Detection of Skin Cancers. Technical Brief No. 11. … Including borderline lesions (high-grade dysplastic nevi, atypical melanocytic proliferations, or hyperplasias … to highlight skin cancers. … General This is a clinically relevant report of the state of the art in non- invasive techniques of skin tumors … Peer Reviewer 4 Results Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzàlez
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
    February 01, 2012 - (Noffsinger AE Serrated polyps and colorectal cancer: new pathway to malignancy. … (Noffsinger AE Serrated polyps and colorectal cancer: new pathway to malignancy. … For cancer alone, there in fact is no need to weight since all cancers were included in the analysis … The footnote gives the weight for cancer plus HGD as 0.13; from Table 1, since there are 19 cancers … Exact Sciences Corporation. 2011; Colorectal Cancer Biology to Therapy, Ahlquist D, Domanico M, Mahoney
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
    January 01, 2020 - For each AE associated with a particular vaccine, what is the average severity (grade 1/mild; grade 2 … For each AE associated with a particular vaccine, what is the average severity (grade 1/mild; grade 2 … For each AE associated with a particular vaccine, what is the average severity (grade 1/mild; grade 2 … For each AE associated with a particular vaccine, what is the average severity (grade 1/mild; grade 2 … National Institutes of Health, National Cancer Institute.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - identified on the interaction between omega-3 fatty acids, both over-the- counter and prescription-grade … observed for total adverse events, incidence of headache, gastrointestinal discomfort, incidence of cancer … and 2g/d decreased TG by 21.5% and 10.1%, respectively. … IPE 2g/d did not have significant effects. … observed for total adverse events, incidence of headache, gastrointestinal discomfort, incidence of cancer
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
    August 01, 2012 - population of malignant plasma cells.1 Multiple myeloma (MM) is the most common malignant plasma cell tumor … , accounting for about 1 percent of all cancer types,1 and the second most common hematologic malignancy … We followed the Methods Guide to grade the strength of the body of evidence (mostly a measure of risk … Ries LAG, Harkins D, Krapcho M, et al. SEER cancer statistics review, 1975-2003. … Cancer Statistics, 2007. CA: A Cancer Journal for Clinicians. 2007;57(1):43-66. 4.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol-amendment.pdf
    February 03, 2025 - Gungor D, Nadaud P, Dreibelbis C, et al. … Gungor D, Nadaud P, Dreibelbis C, et al. … Gungor D, Nadaud P, LaPergola CC, et al. … Dewey KG, Gungor D, Donovan SM, et al. … Wells GA, Shea B, O'Connell D, et al.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - and grade 5 being death due to the event. … https://www.cdc.gov/vaccines/acip/recs/grade/HPV-adults-etr.html. … Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy … [Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer … Investigations • Metabolism and nutrition disorders • Musculoskeletal and connective tissue disorders • Neoplasms
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
    March 25, 2013 - (Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. … We reported our findings consistent with GRADE. … We used GRADE as stated in the EPC Methods Guide. … (Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. … Observational studies are given a lower starting SOE according to GRADE.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/worker-safety-wellness-protocol.pdf
    October 26, 2024 - Dierkes A, Do D, Morin H, Rochman M, Sloane D, McHugh M. … Serchen J, Erickson S, Hilden D. … He D, McInerney M, Mellor J. … Wickizer TM, Franklin G, Fulton-Kehoe D, et al. … Chutiyami M, Bello UM, Salihu D, et al.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
    October 01, 2012 - Grading the Strength of the Body of Evidence The overall strength of evidence grade was determined … on a system developed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE … The grade-of-evidence strength was classified into the following four categories: high, moderate, low … patients (e.g., cardiac disease, diabetes, chronic lung disease, cirrhosis, chronic renal failure, cancer … Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
    July 31, 2012 - McGettigan P, Sly K, O'Connell D, et al. … Moxey A, O'Connell D, McGettigan P, et al. Describing treatment effects to patients. … Communication of uncertainty regarding individualized cancer risk estimates: effects and influential … Owens DK, Lohr KN, Atkins D, et al. … Owens DK, Lohr KN, Atkins D, et al.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - 28 million Americans have some form of cardiovascular disease (CVD), which causes more deaths than cancer … Rating the Quality of Evidence Synthesized Using GRADE (Grading of Recommendations Assessment, Development … Sharma M, Ansari MT, Soares-Weiser K, Abou-setta AM, Ooi TC, Sears M, Yazdi F, Tsertsvadze A, Moher D. … statin in populations requiring intensive treatment and subgroups Strength of Outcome Evidence (GRADE … Abbreviations: ATP III=Adult Treatment Panel III (of the National Cholesterol Education Program); GRADE
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - obstructive symptoms, rectal bleeding, unintentional weight loss, or family history of early colon cancer … Sensation of incomplete evacuation for at least 25 percent of defecations d. … D. … Cassilly D, Kantor S, Knight LC, et al. … Owens DK, Lohr KN, Atkins D, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: